Recent Finacing
Recent Raise
Pi Therapeutics is a Ness Ziona–based preclinical pharmaceutical company developing targeted protein-degradation modulators for oncology, progressing a first-in-class inhibitor toward clinical proof-of-concept from Johns Hopkins‑licensed technology.
